Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8357
|
pubmed:dateCreated |
1983-12-17
|
pubmed:abstractText |
The effectiveness of two rubella vaccines (RA 27/3 and Cendehill) in women vaccinated post partum was compared. Significantly more women who received RA 27/3 gave satisfactory seroconversion responses than women who received Cendehill (97.6% vs 82.2%). This difference was reflected in the geometric mean titres (43.6 vs 17.0). More women who received RA 27/3 had minor side-effects, but the difference was not significant. The serological response to both vaccines was not affected by the concurrent administration of anti-D immunoglobulin. In view of these findings, the replacement of Cendehill vaccine with RA 27/3 vaccine for women vaccinated post partum should be considered.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
29
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
990-2
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6138593-Antibodies, Viral,
pubmed-meshheading:6138593-Clinical Trials as Topic,
pubmed-meshheading:6138593-Female,
pubmed-meshheading:6138593-Humans,
pubmed-meshheading:6138593-Immunoglobulins,
pubmed-meshheading:6138593-Postpartum Period,
pubmed-meshheading:6138593-Pregnancy,
pubmed-meshheading:6138593-Prospective Studies,
pubmed-meshheading:6138593-Random Allocation,
pubmed-meshheading:6138593-Rubella,
pubmed-meshheading:6138593-Rubella Vaccine,
pubmed-meshheading:6138593-Rubella virus
|
pubmed:year |
1983
|
pubmed:articleTitle |
Post-partum rubella immunisation: a controlled trial of two vaccines.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|